Basic Research Open Access
Copyright ©The Author(s) 2004. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Jul 15, 2004; 10(14): 2109-2112
Published online Jul 15, 2004. doi: 10.3748/wjg.v10.i14.2109
Cloning and expression of mouse peroxiredoxin I in IEC-6 Cells
Bo Zhang, Yong-Ping Su, Tao Wang, Feng-Chao Wang, Guo-Ping Ai, Hui Xu, Jun-Ping Wang, Yue-Sheng Huang, Jian-Xin Jiang, Institute of Combined Injury of PLA, State Key Laboratory of Trauma, Burns and Combined Injury, Third Military Medical University, Chongqing 400038, China
Author contributions: All authors contributed equally to the work.
Supported by the National Natural Science Foundation of China, No. 30230360
Correspondence to: Professor Yong-Ping Su, Institute of Combined Injury of PLA, Third Military Medical University, Gaotanyan Street 30, Chongqing 400038, China. suyping@yahoo.com
Telephone: +86-23-68752355 Fax: +86-23-68752279
Received: December 10, 2003
Revised: January 5, 2004
Accepted: February 1, 2004
Published online: July 15, 2004

Abstract

AIM: To clone and express mouse peroxiredoxin I in IEC-6 cells.

METHODS: Total RNAs were isolated from cultured IEC-6 cells, and the coding region of peroxiredoxin I was amplified by RT-PCR. After it was cloned into T-vector and sequenced, pSG5 was used to transiently express peroxiredoxin I in IEC-6 by liposome-mediated transfection, and the expression of peroxiredoxin I was evaluated by RT-PCR and Western blot.

RESULTS: A DNA fragment about 750 bp was amplified from total RNAs of IEC-6 cells using specific primers of peroxiredoxin I. The sequencing confirmed the coding region was successfully cloned into T-vector, which was completely coincident with the sequence in GeneBank. After the EcoR I-BamH I fragment of T-vector containing peroxiredoxin I was inserted into pSG5, the recombinant plasmid was transferred to IEC-6 cells. RT-PCR assay showed that a DNA fragment of 930 bp could be amplified, which indicated the transcription of pSG5-Prx. Western blot confirmed the expression of peroxiredoxin I in IEC-6 cells.

CONCLUSION: Mouse peroxiredoxin I can be successfully expressed in IEC-6 cells.




INTRODUCTION

Peroxiredoxin (Prx) is a novel defined protein family which plays a critical role in reducing hydrogen peroxide with hydrogen derived from NAD(P)H[1-3]. The first member of this family was discovered as a 25 ku protein in yeast[4]. All Prx proteins contain a conserved cysteine residue in the N-terminal region that is the active site of catalysis. In mammal cells, there are six isoforms of peroxiredoxin, which can be devided into two subgroups, termed as 1-Cys Prx (VI) and 2-Cys Prx (I-V)[5,6]. The proteins of 2-Cys Prx subgroup contain another cysteine residue in the C-terminal portion of the molecule. Prx isoforms are distributed differently within cells and therefore with different functions. Prx I and II are localized to the cytosol[7,8], whereas Prx III has a mitochondrial-targeting signal and is localized in mitochondrion[9]. Prx IV is secreted out of cells because of its N-terminal sequence for secretion. Prx V is found in mitochondrion as long form of this protein, but it also exists in peroxisome as short form[10]. Same as Prx I and II, Prx VI is also found in cytosol[11].

Prx I, which belongs to 2-Cys subgroup, is also known as MSP23, PAG and NEEF-A[12-14]. Prx I is involved in redox regulation of the cell, such as reducing peroxides by reducing equivalents provided through the thioredoxin system but not from glutaredoxin. Prx I is found in abundance in the cytoplasm of cells as homodimers. Its cDNA was first cloned from mouse peritoneal macrophage encoding a protein of 23 ku. Now the antioxidative molecular mechanism of Prx I is elucidated by several researches on molecular structure has been performed. From the results of biochemical and physiological studies, Prx I has been implicated in a number of cellular functions, such as cell proliferation and differentiation, enhancement of the natural killer cell activity, and intracellular signaling, in addition to the antioxidant activity[15-17]. Further studies have shown that the expression of Prx I is increased in cancer cells, indicating it may be related to cancer development or progression[18]. We postulate that it may have an activity of anti-tumor development.

In our previous study, we found the expression of Prx I was up regulated by ionizing radiation in mouse intestinal epithelia[19]. This was coincident with the results of other researchers[20]. As a step to further study the biochemical functions of Prx I, we cloned the coding region of this gene and expressed it in IEC-6 cells. Our data showed that Prx I could be successfully expressed in this kind of cells.

MATERIALS AND METHODS
Materials

Male BALB/c mice, 58-62 d of age (weight 20-24 g), were purchased from Animal Center in Third Military Medical University, and housed in conventional cages with free access to drinking water and standard chow. Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine serum were purchased from Hyclone (Logan, USA). RNA PCR kit and T-vector were obtained from Takara (Dalian, China), and antibodies were from Santa Cruz (California, USA). Reagent for RNA isolation was from Roche Ltd. (Roche, USA). Plasmid pSG5 was a kindly gift from Dr. Chen Jian (Department of Biochemistry, Third Military Medical University). The specific primers were synthesized by Shanghai Shenyou Shengwu Jishu Corporation. Other chemicals not mentioned above were domestic made.

Isolation of total RNAs

Mouse intestinal epithelial cells were isolated as previously described[21]. After the cell pipette washed with cold PBS (0.01 mol/L, pH7.4), the cells were lysed with Tripure solution. All performs were according to the manufacturer’s instructions. The quality of isolated RNAs was checked by electrophoresis.

RT-PCR

The coding region of Prx I was amplified by RT-PCR with forward primer, 5’CGAATTCGTTCTCACGGCTCTTTCTGTTT3’ (P1) and backward primer, 5’AGGATCCTTCTGGCTGCTCAATGC TGC3’ (P2). One microgram of total RNAs was added into each reaction. After the reverse transcription was performed at 50 °C for 30 min, the amplification was carried out with one denaturing cycle of 3 min at 94 °C, then 28 cycles consisting of denaturation at 94 °C for 40 s, annealing at 58 °C for 40 s, and extension at 72 °C for 40 s, and one additional extension at 72 °C for 5 min. RT-PCR products were analyzed on 12 g/L agarose gel. To validate the transcription of recombinant plasmid, the mRNA of transfected IEC-6 cells was amplified by RT-PCR with primers P2 and P3 (5’AAAGCTGGATCGATCCTGAG3’). The procedure in details was performed according to the manufacturer’s instructions.

Construction of expression vector

The amplified DNA was separated by electrophorsis and purified from gels. Then 1µL of T-vector, 1µL of T4 DNA ligase and 2µL of 10 × buffer were added to the purified RT-PCR product, and incubated at 16 °C overnight. Competent bacteria of E. coli JM109 were transformed with the linkage product, and then spread on a LB agarose plate containing ampicillin and X-gal. The inserted DNA into T-vector of 3 random monoclonal colonies was sequenced, and the colony was termed as pT-Prx. To construct the recombinant expression vector, the EcoR I-BamH I fragment of pT-Prx was inserted into vector pSG5, which could transfect IEC-6 cells.

Cell culture and transfection

IEC-6 cells were cultivated at 37 °C in an atmosphere containing 100 mL/L CO2 in air. The culture medium comprised of DMEM containing 100 mL/L fetal calf serum, penicillin (100 U/mL), and streptomycin (100 µg/mL). Exponentially growing cells were transferred to 100 mL culture dishes and cultured for 24 h to yield about 40% confluency at the time of transfection. Before transfection, 30 µg of DOTAP was diluted with 70 µL of HBS solution (20 mmol/L HEPES, 150 mmol/L NaCl, pH7.4), and 5 µg of DNA was diluted to 0.1µg/µL with the same solution. The mixture of DNA and DOTAP was prepared by gently mixing them together and incubated for 15 min at room temperature. To prepare cells for transfection, IEC-6 cells were washed twice with serum-free medium. After the cells were incubated with the mixture of DNA and DOTAP in 2 mL of serum-free medium for 4 h, the cells were washed with serum-free medium, followed by further culture for 16 h. Transfection was repeated one more time. At the time of 24 h after the second transfection, the cells were collected for RNA and proteins isolation.

Immunoblotting

IEC-6 cells were collected and washed with ice-cold PBS (0.01 mol/L, pH7.4) after transfection. Total proteins were isolated with RPI solution. The extraction mixture was centrifuged at 12000 g at 4 °C for 20 min. The supernatants were transferred to a clean tube and stored at -70 °C as aliquots. The protein concentration was determined using Bradford dye-binding assay with bovine serum albumin as a standard. Total proteins were separated on 120 g/L SDS-polyacrylamide gel, and then transferred to nitrocellulose membranes. After being blocked for 1 h with the Tris/NaCl (50 mmol/L Tris-HCl, 200 mmol/L NaCl, 0.5 g/L Tween-20, pH7.4) containing 20 g/L BSA, the membranes were probed with the goat anti-mouse Prx I polyclonal antibody. Immunoreactive bands were visualized with solution containing 1 mg/mL DAB and 0.1 mL/L H2O2. The expression of Prx I was normalized by that of GAPDH.

RESULTS
Amplification of the cDNA of Prx I

Total RNAs were isolated with 3 main bands appeared on agarose gels electrophoresis (Figure 1A). Message RNAs were smeared on the gel. After 28 cycles of RT-PCR, the products were run on 12 g/L agarose gel. A DNA band about 750 bp was visualized which was coincident with the length of the Prx I cDNA and could be cloned in the next step (Figure 1).

Figure 1
Figure 1 Amplification of Peroxiredoxin I by RT-PCR. A: total RNAs were isolated from mouse intestinal epithelia; three bands were visualized on agarose gel, which represented the main ribosome RNA of the cells. B: amplification of the coding region of peroxiredoxin I applying RT-PCR.
Cloning of Prx I

After the PCR product was ligated to T-vector, the linkage mixture transformed competent bacteria of JM109, and white colonies grew on LB plate containing ampicillin, X-gal and IPTG. Inserted DNA of 3 random colonies was sequenced, and the DNA was completely coincident with the sequence in GeneBank (data not shown). Then the inserted DNA of pT-Prx was digested with EcoR I and BamH I, purified, and inserted into vector pSG5. The recombinant expression vector was termed as pSG5-Prx (Figure 2). This recombinant plasmid was directly applied in cell transfection.

Figure 2
Figure 2 Recombinant expression vector pSG5-Prx. A: diagrams of the expression vector pSG5-Prx. B: electrophoresis map of this vector (EcoR I and BamH I). λ/HindIII marker was loaded to estimate the relative molecular weight of the expression vector.
Transcription of pSG5-Prx in IEC-6 Cells by RT-PCR

We transfected IEC-6 cells with pSG5-Prx using pSG5 as a control. The cells grew very well during the period of transfection. Total RNAs of transfected IEC-6 cells were isolated after the second transfection using TriPure solution. Transcription of the recombinant plasmid was detected by applying RT-PCR with primers P2 and P3. The result showed that 2 DNA bands were visualized on agarose gel. Because the beta-globin intron (Figure 2A) in the primary transcript was spliced, the length of RT-PCR product based on mature mRNA was about 817 bp. However, the length of the other DNA band was about 1399 bp, which was the PCR product using the recombinant plasmid as template (Figure 3).

Figure 3
Figure 3 Detection of the transcription of recombinant vector pSG5-Prx by RT-PCR. Total RNAs isolated from transfected cells were applying for RT-PCR analysis with primers P2 and P3. Lane 1: DNA marker DL 2000, Lane 2: RT-PCR product, Lane 3: PCR product using purified recombinant vector as template.
Expression of Prx I in IEC-6 Cells

Total proteins of transfected IEC-6 cells were isolated after the second transfection and separated by SDS-PAGE. The blots were probed with specific antibodies against Prx I and GAPDH. Relative protein level was determined by quantitating the intensity of the bands with a densitometer. The ratio of the intensity of Prx I/GAPDH was automatically compared by Quantity One software (Bio-Rad Corp.). The result showed that the expression of Prx I was increased in pSG5-Prx transfected IEC-6 cells (50% more than the control cells) (Figure 4). This indicated that the recombinant plasmid could be transcripted and translated in IEC-6 cells.

Figure 4
Figure 4 Immunoblotting of peroxiredoxin I of transfected and normal IEC-6 cell.
DISCUSSION

IEC-6 cell line was derived from normal rat intestinal epithelia. Its living condition for stable passage was successfully established after trials. The cell line was testified to be the small intestinal epithelial cell by electron microscopy and immunohistochemistry, and has been applied to some related research work[22]. It is rational to apply this cell line in vitro to mimic the intestinal epithelia in vivo.

To further study the biochemical and physiological function of Prx I, we cloned the coding region of this protein and over expressed it in IEC-6 cells in this study. The cDNA of Prx I was first cloned in 1994 applying differential hybridization technique, which was named as MSP23[23]. Treatment with diethylmaleate or glucose/glucose oxidase markedly enhanced the induction of its transcription, and the mount of its protein in the cells rapidly increased. Moreover, the cDNAs corresponding to the thiol-specific antioxidant (TSA), which encoded a protein termed as Prx, has been cloned and sequenced in yeast and mammalian cells[24]. From the results of biochemical and physiological studies, Prx I has been involved in association with a variety of diverse cellular functions including proliferation, differentiation, and immune response. However, the detailed pathophysiological functions of this protein remain unknown.

The most striking finding of Prx I was that it was increased in many kinds of tumor cells. Moreover, some researchers thought it might be a potential tumor marker[25]. Prx I was over-expressed in human breast cancer tissues compared to normal tissues[26]. Using comparative proteome analysis between human normal (BEAS 2B) and malignant (A549) lung epithelial cells, Chang et al[27] found that Prx I was increased more than twofold reproducibly. Additionally, Prx I expression levels in follicular neoplasm and thyroiditis group were significantly higher than that of the control group, though papillary carcinoma group did not show statistical significance[25]. All these data suggested Prx I was involved in tumor development or progression, and it might be a new target for gene therapy of tumor cells.

It was suggested that Prx I was a radiation responsive gene. Lee et al[28] demonstrated, when the irradiated testis was examined, Prx I was found to be transiently up-regulated. Its highly homologous gene Prx II was increased in tissues isolated from the patients who did not respond to radiation therapy. However, treatment with a Prx II antisense decreased the expression of Prx II, enhancing the radiation sensitivity of cells[29].

In this study, we found pSG5 was an efficient expression vector of mammal cells[30]. Though it has no screen marker, the expression of recombinant plasmid can be easily verified at mRNA level applying RT-PCR technology owing to the globin intron of this vector. Because of the existence of the vector DNA in the sample purified by applying Tripure solution, two kinds of RT-PCR product were displayed on agarose gel, which represented different PCR template. After the second transfection, most of the cells expressed the exogenous vector, and the protein was accumulated in these cells, which could be detected by immunoblotting. We will further study the biochemical and physiological role in radiation response of this protein.

Footnotes

Edited by Kumar M and Xu FM

References
1.  Rhee SG, Kang SW, Chang TS, Jeong W, Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52:35-41.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 482]  [Cited by in F6Publishing: 479]  [Article Influence: 20.8]  [Reference Citation Analysis (0)]
2.  Fujii J, Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 2002;7:123-130.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 301]  [Cited by in F6Publishing: 300]  [Article Influence: 14.3]  [Reference Citation Analysis (0)]
3.  Butterfield LH, Merino A, Golub SH, Shau H. From cytoprotection to tumor suppression: the multifactorial role of peroxiredoxins. Antioxid Redox Signal. 1999;1:385-402.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 102]  [Cited by in F6Publishing: 101]  [Article Influence: 4.0]  [Reference Citation Analysis (0)]
4.  Kim K, Kim IH, Lee KY, Rhee SG, Stadtman ER. The isolation and purification of a specific "protector" protein which inhibits enzyme inactivation by a thiol/Fe(III)/O2 mixed-function oxidation system. J Biol Chem. 1988;263:4704-4711.  [PubMed]  [DOI]  [Cited in This Article: ]
5.  Chang TS, Jeong W, Choi SY, Yu S, Kang SW, Rhee SG. Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation. J Biol Chem. 2002;277:25370-25376.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 194]  [Cited by in F6Publishing: 203]  [Article Influence: 9.2]  [Reference Citation Analysis (0)]
6.  Rhee SG, Chang TS, Bae YS, Lee SR, Kang SW. Cellular regulation by hydrogen peroxide. J Am Soc Nephrol. 2003;14:S211-S215.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 264]  [Cited by in F6Publishing: 261]  [Article Influence: 12.4]  [Reference Citation Analysis (0)]
7.  Lee TH, Yu SL, Kim SU, Lee KK, Rhee SG, Yu DY. Characterization of mouse peroxiredoxin I genomic DNA and its expression. Gene. 1999;239:243-250.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 11]  [Cited by in F6Publishing: 13]  [Article Influence: 0.5]  [Reference Citation Analysis (0)]
8.  Chung YM, Yoo YD, Park JK, Kim YT, Kim HJ. Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res. 2001;21:1129-1133.  [PubMed]  [DOI]  [Cited in This Article: ]
9.  Choi JH, Kim TN, Kim S, Baek SH, Kim JH, Lee SR, Kim JR. Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas. Anticancer Res. 2002;22:3331-3335.  [PubMed]  [DOI]  [Cited in This Article: ]
10.  Seo MS, Kang SW, Kim K, Baines IC, Lee TH, Rhee SG. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem. 2000;275:20346-20354.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 358]  [Cited by in F6Publishing: 353]  [Article Influence: 14.7]  [Reference Citation Analysis (0)]
11.  Chen JW, Dodia C, Feinstein SI, Jain MK, Fisher AB. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem. 2000;275:28421-28427.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 267]  [Cited by in F6Publishing: 261]  [Article Influence: 10.9]  [Reference Citation Analysis (0)]
12.  Kawai S, Takeshita S, Okazaki M, Kikuno R, Kudo A, Amann E. Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoblastic cells. J Biochem. 1994;115:641-643.  [PubMed]  [DOI]  [Cited in This Article: ]
13.  Shau H, Butterfield LH, Chiu R, Kim A. Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics. 1994;40:129-134.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 88]  [Cited by in F6Publishing: 96]  [Article Influence: 3.2]  [Reference Citation Analysis (0)]
14.  Prospéri MT, Apiou F, Dutrillaux B, Goubin G. Organization and chromosomal assignment of two human PAG gene loci: PAGA encoding a functional gene and PAGB a processed pseudogene. Genomics. 1994;19:236-241.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 37]  [Article Influence: 1.2]  [Reference Citation Analysis (0)]
15.  Yang KS, Kang SW, Woo HA, Hwang SC, Chae HZ, Kim K, Rhee SG. Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid. J Biol Chem. 2002;277:38029-38036.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 359]  [Cited by in F6Publishing: 361]  [Article Influence: 16.4]  [Reference Citation Analysis (0)]
16.  Ishii T, Itoh K, Sato H, Bannai S. Oxidative stress-inducible proteins in macrophages. Free Radic Res. 1999;31:351-355.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 98]  [Cited by in F6Publishing: 98]  [Article Influence: 3.9]  [Reference Citation Analysis (0)]
17.  Neumann CA, Krause DS, Carman CV, Das S, Dubey DP, Abraham JL, Bronson RT, Fujiwara Y, Orkin SH, Van Etten RA. Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression. Nature. 2003;424:561-565.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 604]  [Cited by in F6Publishing: 605]  [Article Influence: 28.8]  [Reference Citation Analysis (0)]
18.  Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, Waltmire CN, Crowley C, Dvorakova K, Bernstein C, Craven M. Development and molecular characterization of HCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis. 2002;23:2063-2080.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 60]  [Cited by in F6Publishing: 63]  [Article Influence: 2.9]  [Reference Citation Analysis (0)]
19.  Wei YJ, Zhang B, Su YP, Liu XH, Wang FC, Ai GP. Effect of ionizing radiation on the expression of Prx I and Prx VI gene in murine intestinal epithelial cells. Chongqing Med J. 2003;32:1343-1345.  [PubMed]  [DOI]  [Cited in This Article: ]
20.  Chen WC, McBride WH, Iwamoto KS, Barber CL, Wang CC, Oh YT, Liao YP, Hong JH, de Vellis J, Shau H. Induction of radioprotective peroxiredoxin-I by ionizing irradiation. J Neurosci Res. 2002;70:794-798.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 46]  [Cited by in F6Publishing: 46]  [Article Influence: 2.1]  [Reference Citation Analysis (0)]
21.  Zhang B, Su YP, Ai GP, Liu XH, Wang FC, Cheng TM. Differentially expressed proteins of gamma-ray irradiated mouse intestinal epithelial cells by two-dimensional electrophoresis and MALDI-TOF mass spectrometry. World J Gastroenterol. 2003;9:2726-2731.  [PubMed]  [DOI]  [Cited in This Article: ]
22.  Wood SR, Zhao Q, Smith LH, Daniels CK. Altered morphology in cultured rat intestinal epithelial IEC-6 cells is associated with alkaline phosphatase expression. Tissue Cell. 2003;35:47-58.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 37]  [Cited by in F6Publishing: 37]  [Article Influence: 1.8]  [Reference Citation Analysis (0)]
23.  Ishii T, Yamada M, Sato H, Matsue M, Taketani S, Nakayama K, Sugita Y, Bannai S. Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J Biol Chem. 1993;268:18633-18636.  [PubMed]  [DOI]  [Cited in This Article: ]
24.  Chae HZ, Rhee SG. A thiol-specific antioxidant and sequence homology to various proteins of unknown function. Biofactors. 1994;4:177-180.  [PubMed]  [DOI]  [Cited in This Article: ]
25.  Yanagawa T, Ishikawa T, Ishii T, Tabuchi K, Iwasa S, Bannai S, Omura K, Suzuki H, Yoshida H. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 1999;145:127-132.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 90]  [Cited by in F6Publishing: 96]  [Article Influence: 3.8]  [Reference Citation Analysis (0)]
26.  Noh DY, Ahn SJ, Lee RA, Kim SW, Park IA, Chae HZ. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 2001;21:2085-2090.  [PubMed]  [DOI]  [Cited in This Article: ]
27.  Chang JW, Jeon HB, Lee JH, Yoo JS, Chun JS, Kim JH, Yoo YJ. Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun. 2001;289:507-512.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 93]  [Cited by in F6Publishing: 96]  [Article Influence: 4.2]  [Reference Citation Analysis (0)]
28.  Lee K, Park JS, Kim YJ, Soo Lee YS, Sook Hwang TS, Kim DJ, Park EM, Park YM. Differential expression of Prx I and II in mouse testis and their up-regulation by radiation. Biochem Biophys Res Commun. 2002;296:337-342.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 52]  [Cited by in F6Publishing: 56]  [Article Influence: 2.5]  [Reference Citation Analysis (0)]
29.  Park SH, Chung YM, Lee YS, Kim HJ, Kim JS, Chae HZ, Yoo YD. Antisense of human peroxiredoxin II enhances radiation-induced cell death. Clin Cancer Res. 2000;6:4915-4920.  [PubMed]  [DOI]  [Cited in This Article: ]
30.  Rose K, Steinbüchel A. Construction and intergeneric conjugative transfer of a pSG5-based cosmid vector from Escherichia coli to the polyisoprene rubber degrading strain Micromonospora aurantiaca W2b. FEMS Microbiol Lett. 2002;211:129-132.  [PubMed]  [DOI]  [Cited in This Article: ]  [Cited by in Crossref: 15]  [Cited by in F6Publishing: 15]  [Article Influence: 0.7]  [Reference Citation Analysis (0)]